Literature DB >> 24352631

Amniotic membrane properties and current practice of amniotic membrane use in ophthalmology in Slovenia.

Tina Cirman1, Matej Beltram, Petra Schollmayer, Primož Rožman, Mateja Erdani Kreft.   

Abstract

Amniotic membrane (AM) is the innermost, multilayered part of the placenta. When harvested, processed and stored properly, its properties, stemming from AM biological composition, make it a useful tissue for ophthalmic surgery. AM was shown to have several beneficial effects: it promotes epithelization, has antimicrobial effects, decreases inflammation, fibrosis and neovascularization. Many case reports and case series as well as practical experience (e.g. reconstruction of conjunctival and corneal defects, treatment of corneal ulcers) demonstrated the beneficial effect of AM for different ophthalmological indications. The combination of the above mentioned beneficial effects and reasonable mechanical properties are also the reason why AM is used as a substrate for ex vivo expansion of epithelial progenitor cells. Recently, amnion-derived cells, which also have stem cell characteristics, have been proposed as potential contributors to cell-based treatment of ocular surface disease. However, the use of AM remains one of the least standardized methods in ophthalmic surgery. In this review, the various properties of AM and its current clinical use in ophthalmology in Slovenia are discussed.

Entities:  

Mesh:

Year:  2013        PMID: 24352631     DOI: 10.1007/s10561-013-9417-6

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  4 in total

1.  Conjunctival structural and functional reconstruction using acellular bovine pericardium graft (Normal GEN®) in rabbits.

Authors:  Danping Huang; Bing Xu; Xiaonan Yang; Binbin Xu; Jing Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-01       Impact factor: 3.117

2.  Processing methods for human amniotic membrane as scaffold for tissue engineering with mesenchymal stromal human cells.

Authors:  L Echarte; G Grazioli; L Pereira; A Francia; H Pérez; W Kuzuian; W Vicentino; H Pardo; A Mombrú; Á Maglia; C Touriño; I Álvarez
Journal:  Cell Tissue Bank       Date:  2022-07-29       Impact factor: 1.752

3.  Case Report: Wound Closure Acceleration in a Patient With Toxic Epidermal Necrolysis Using a Lyophilised Amniotic Membrane.

Authors:  Bretislav Lipový; Martin Hladík; Petr Štourač; Serhiy Forostyak
Journal:  Front Bioeng Biotechnol       Date:  2021-04-16

4.  Case Report: Freeze-Dried Human Amniotic Membrane Allograft for the Treatment of Chronic Wounds: Results of a Multicentre Observational Study.

Authors:  Iveta Schmiedova; Zuzana Ozanova; Elen Stastna; Ludmila Kiselakova; Bretislav Lipovy; Serhiy Forostyak
Journal:  Front Bioeng Biotechnol       Date:  2021-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.